Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein (HSIC) has completed the acquisition of substantially all assets of Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs). The deal, initially announced on November 20, 2024, brings Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia into Henry Schein's team, incorporating their healthcare industry and product expertise.
The transaction was facilitated by Provident Healthcare Partners, with their deal team led by Managing Director Kevin Palamara. Robinson & Cole provided legal counsel to Acentus during the acquisition process. Acentus has developed a distinctive CGM platform that has shown significant growth since its establishment.
Henry Schein (Nasdaq: HSIC) has completed the acquisition of Acentus, a Tampa-based national medical supplier specializing in Continuous Glucose Monitors (CGMs) with annual revenue of approximately $35 million. The transaction is expected to be neutral to 2025 non-GAAP earnings per share and accretive thereafter.
This acquisition follows Henry Schein's previous acquisitions of Prism Medical Products (2021), Shield Healthcare, and Mini Pharmacy (2023), strengthening its position in the homecare medical supplies market. With the addition of Acentus, Henry Schein's homecare medical products platform will now have an annual revenue base exceeding $350 million.
The four Acentus founders will join Henry Schein, bringing their expertise in the product category and healthcare industry. The acquisition aims to enhance Henry Schein's ability to serve customers through direct CGM product delivery to patients' homes.
Henry Schein (Nasdaq: HSIC) has announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support Los Angeles area fires relief efforts. The initiative includes a total commitment of up to $300,000, comprising:
- $25,000 each from the Company and Foundation
- Up to $50,000 in matching Team Schein Member contributions
- Up to $150,000 in essential healthcare supplies
The company has established a Customer Emergency Support Hotline (800-999-9729) for affected dental and medical professionals. The initiative aims to provide critical healthcare supplies and resources to communities impacted by the wildfires, working with trusted relief and recovery charitable partners.
Henry Schein (NASDAQ: HSIC) has activated its Customer Emergency Support Hotline at 800-999-9729 to assist dental and medical professionals affected by the ongoing California fires. The hotline provides 24/7 support, with live assistance from Team Schein Members available from 8 a.m. to 8 p.m. Eastern Time.
The company offers resources to help practitioners manage operational, logistical, and financial challenges resulting from the natural disaster. These include an Emergency Preparedness Guide to minimize disaster impact and an Emergency Recovery Guide to assist in practice rebuilding efforts.
Henry Schein (HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in J.P. Morgan's Healthcare Investor Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 3:00 p.m. PST / 6:00 p.m. EST at The Westin St. Francis Hotel in San Francisco. Investors and interested parties can access the live webcast through www.henryschein.com/IRwebcasts, with replay options available on the company's website after the presentation.
Henry Schein (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in two major investor conferences this December. The company will present at Piper Sandler's Healthcare Conference in New York on December 4, 2024, at 11:00 a.m. Eastern time, and at the Evercore ISI HealthCONx Conference in Coral Gables, Florida, on December 5, 2024, at 9:10 a.m. Eastern time. Both presentations will be available via live webcast on the company's website, with replays accessible afterward.
Henry Schein (NASDAQ: HSIC) has signed an agreement to acquire Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs) with annual revenue of $35 million. This acquisition follows Henry Schein's previous acquisitions of Prism Medical Products, Shield Healthcare, and Mini Pharmacy, expanding their homecare medical products platform to an annual revenue base of approximately $350 million. The transaction is expected to be neutral to 2024 non-GAAP earnings per share, accretive thereafter, and close in Q1 2025. Acentus's founders will join Henry Schein post-acquisition.
Henry Schein (HSIC) reported Q3 2024 financial results with total net sales of $3.2 billion, up 0.4% from Q3 2023. The company achieved GAAP EPS of $0.78 and non-GAAP EPS of $1.22. Operating cash flow was $151 million for Q3, with year-to-date cash flow of $644 million. The company increased its 2024 full-year non-GAAP EPS guidance to $4.74-$4.82 from $4.70-$4.82. During Q3, Henry Schein repurchased approximately 2.0 million shares at an average price of $69.09 per share, totaling $135 million.
Henry Schein (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in two major investor conferences this November. The company will present at Stifel's Healthcare Conference in New York on November 18, 2024, at 9:45 a.m. EST, and at the Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. GMT/8:30 a.m. EST. Both presentations will be available via live webcast on the company's website, with replays accessible afterward.
Henry Schein, Inc. (Nasdaq: HSIC) has opened its Customer Assistance Hotline for dental and medical professionals who may be affected by Hurricane Milton. The toll-free number 800-999-9729 is available 24/7, with real-time assistance from 8 a.m. to 8 p.m. Eastern Time. The company offers support for operational, logistical, or financial issues resulting from hurricane damage.
Stanley M. Bergman, Chairman and CEO of Henry Schein, emphasized the company's commitment to helping customers prepare for and recover from natural disasters. Henry Schein provides resources such as an Emergency Preparedness Guide and an Emergency Recovery Guide for office-based healthcare practitioners to minimize impact and facilitate swift recovery.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
